Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/15212
Título : | Psycho Neuroendocrino Immune (PNEI) therapy of cancer beyond melatonin | Autor : | Lissoni, Paolo Colgiago, Massimo Rovelli, Franco Messina, Giusy Porro, Giorgio Monzon, Alejandra Merlini, Desirée Di Fede, Giuseppe Cardinali, Daniel Pedro |
Palabras clave : | MELATONINA; CANNABINOIDES; NEUROINMUNOMODULACION; OXITOCINA; CANCER; CANCER DE MAMA | Fecha de publicación : | 2021 | Editorial : | Crimson Publishers | Cita : | Lissoni, P., et al. Psycho Neuroendocrino Immune (PNEI) therapy of cancer beyond melatonin [en línea]. Novel Approaches in Cancer Study. 2021. 6(4) doi:10.31031/NACS.2021.06.000641 Disponible en: https://repositorio.uca.edu.ar/handle/123456789/15212 | Resumen : | Abstract: The recent advances in psycho-neuroendocrino-immunology (PNEI) have demonstrated the existence of a natural anticancer neuroendocrine system, mainly expressed by the pineal gland, endocannabinoid system, oxytocin, and Ang 1-7. Moreover, cancer progression has appeared to be associated with a progressive decline in the pineal and cannabinoid system functions. A new approach to cancer therapy according to a PNEI strategy could simply consist of the correction of the main cancer-related neuroimmune and neuroendocrine alterations through the exogenous administration of the same human natural anticancer molecules, whose production declines with cancer progression. PNEI therapy of cancer, because of its complete lack of toxicity, could be applied also to patients, who failed to respond to the conventional anticancer treatments. Most data available up to now regard the treatment with the pineal anticancer hormone melatonin (MLT), whose efficacy has been proven to be a dose-dependent phenomenon. Preliminary results with other human antitumor molecules, mainly the pineal indole 5-MTT, cannabinoids, oxytocin and probably in particular Ang 1-7, could further amplify the already interesting results obtained with high-dose MLT alone in untreatable advanced cancer patients. | URI : | https://repositorio.uca.edu.ar/handle/123456789/15212 | ISSN : | 2637-773X | Disciplina: | MEDICINA | DOI: | 10.31031/NACS.2021.06.000641 | Derechos: | Acceso abierto |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
psycho-neuroendocrino-immune.pdf | 537,62 kB | Adobe PDF | Visualizar/Abrir |
Visualizaciones de página(s)
75
comprobado en 27-abr-2024
Descarga(s)
87
comprobado en 27-abr-2024
Google ScholarTM
Consultar
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons